How will the COVID-19 pandemic affect cancer treatment and research?
The most recent article from urotoday explores a number of the questions raised by members of HealthUnlocked over the last week or two about the impact of the COVID-19 pandemic on cancer treatment and research. Also discussed are the strategies in place across various locations to minimize the risks to patients.
The references noted in the article are also well worth reading. Links can be located at the end of the item.
urotoday.com/recent-abstrac...
Also from urotoday is a series of videos covering various issues related to cancer and COVID-19
1.Considerations of GU Cancer Patients - Treatments in the New Reality of COVID-19
Petros Grivas, MD, Ph.D, Brian Rini, MD, & Ali Khaki, MD
Petros Grivas, Brian Rini, and Ali Khaki discuss the current status of the COVID-19 global pandemic and its impacts on the current ongoing care for patients receiving treatment for cancer and for patients currently on clinical trials. It is clear that there is no data on oncologic outcomes as the virus is rapidly spreading. Drs. Rini, Khaki, and Grivas discuss aspects of treatment selection and treatment decision-making for each patient.
urotoday.com/video-lectures...
2. COVID-19 Impacting GU Cancer Care - A. Oliver Sartor
A. Oliver Sartor, MD
Oliver Sartor joins Alicia Morgans sharing his perspective of the novel coronavirus 2019 (COVID-19) and the current disruption in healthcare. Dr. Sartor discusses variables his institution is experiencing with personnel resources, the importance of staying in close communication with patients and considerations of their care in this challenging time. Drs. Sartor and Morgans also discuss treatment decisions that they are weighing for their GU cancer patients since there is no data.
urotoday.com/video-lectures...
3. Safe and Effective Cancer Care During the COVID-19 Pandemic
Toni K. Choueiri, MD
Joining Alicia Morgans is Toni Choueiri to share the measures he is taking at his clinic to support safe and effective cancer care during the COVID-19 pandemic. Dr. Choueiri, the Director of the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute, shares that in addition to following strict screening processes, his team is working to prioritize or pause patient treatments who may be at risk of immunosuppression.
urotoday.com/video-lectures...
4. COVID-19 and Cancer Care at St. Barts Cancer Institute in London UK
Thomas Powles, MBBS, MRCP, MD
Thomas Powles from Barts Cancer Institute in London joins Alicia Morgans to discuss how the GU medical oncology and urologic oncology communities are preparing for and caring for people with genitourinary malignancies in light of the global COVID-19 pandemic.